Diagnostics & Healthcare News
BioIntelliSense Announces FDA Clearance of the BioSticker, a Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring
BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announces the U.S. commercial launch of its medical grade Data-as-a-Service (DaaS) platform and FDA 510(k) clearance of the BioSticker™ on-body sensor for scalable remote care. BioIntelliSense offers a new...